Cargando…

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease

Latest data suggest that placental growth factor (PLGF), growth differentiation factor-15 (GDF-15) and hepatic growth factor (HGF) are involved in hepatic fibrogenesis. Diagnostic performance of these markers for non-invasive liver fibrosis prediction was evaluated based on liver histology and stiff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krawczyk, Marcin, Zimmermann, Simone, Hess, Georg, Holz, Robert, Dauer, Marc, Raedle, Jochen, Lammert, Frank, Grünhage, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354278/ https://www.ncbi.nlm.nih.gov/pubmed/28301573 http://dx.doi.org/10.1371/journal.pone.0173506

Ejemplares similares

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Identification of Combined Genetic Determinants of Liver Stiffness within the SREBP1c-PNPLA3 Pathway
por: Krawczyk, Marcin, et al.
Publicado: (2013)

Increased Circulating VAP-1 Levels Are Associated with Liver Fibrosis in Chronic Hepatitis C Infection
por: Kraemer, Marcel, et al.
Publicado: (2019)

A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population
por: Müllenbach, Roman, et al.
Publicado: (2012)

Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022)

Serum 25-hydroxyvitamin D levels and mortality risk in patients with liver cirrhosis: a protocol for a systematic review and meta-analysis of observational studies
por: Völker, Désirée, et al.
Publicado: (2019)

Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice
por: Weber, Susanne N., et al.
Publicado: (2021)

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
por: Wunsch, Ewa, et al.
Publicado: (2016)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease
por: Kawamura, Nobuyoshi, et al.
Publicado: (2022)

Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART
por: Grünhage, F, et al.
Publicado: (2010)

Liver stiffness and liver function index in liver fibrosis patients afflicted with electrocardiographic abnormalities
por: Hajiani, Eskandar, et al.
Publicado: (2022)

TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver
por: Weber, Susanne Nicole, et al.
Publicado: (2016)

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial
por: Casper, Markus, et al.
Publicado: (2015)

Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis
por: Saneyasu, Takaoki, et al.
Publicado: (2016)

Childhood obesity, cardiovascular and liver health: a growing epidemic with age
por: Faienza, Maria Felicia, et al.
Publicado: (2020)

Can genetic testing guide the therapy of cholestatic pruritus? A case of benign recurrent intrahepatic cholestasis type 2 with severe nasobiliary drainage‐refractory itch
por: Holz, Robert, et al.
Publicado: (2018)

The Frequent Adiponutrin (PNPLA3) Variant p.Ile148Met Is Associated with Early Liver Injury: Analysis of a German Pediatric Cohort
por: Krawczyk, Marcin, et al.
Publicado: (2015)

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter
por: Arslanow, Anita, et al.
Publicado: (2016)

Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3 ( I148M ) risk allele
por: Kirchmeyer, Mélanie, et al.
Publicado: (2023)

Gravity assistance enables liver stiffness measurements to detect liver fibrosis under congestive circumstances
por: Suda, Takeshi, et al.
Publicado: (2022)

Liver stiffness and arterial stiffness/abnormal central hemodynamics in the early stage of heart failure
por: Iwasaki, Yoichi, et al.
Publicado: (2018)

MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis
por: Janik, Maciej K., et al.
Publicado: (2021)

Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools
por: Lang, Sonja, et al.
Publicado: (2020)

Nuclear Receptor Variants in Liver Disease
por: Müllenbach, Roman, et al.
Publicado: (2012)

Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation
por: Alsaied, Tarek, et al.
Publicado: (2020)

Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients
por: Yuan, Xiaoling, et al.
Publicado: (2019)

TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
por: Basyte-Bacevice, Viktorija, et al.
Publicado: (2019)

Non-invasive evaluation of liver stiffness after splenectomy in rabbits with CCl(4)-induced liver fibrosis
por: Wang, Ming-Jun, et al.
Publicado: (2016)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

The usefulness of noninvasive liver stiffness assessment using shear-wave elastography for predicting liver fibrosis in children
por: Lee, Seunghyun, et al.
Publicado: (2021)

The Prevalence of Liver Fibrosis Stages on More than 23,000 Liver Stiffness Measurements by Vibration-Controlled Transient Elastography: A Single Center Study
por: Lazar, Alin, et al.
Publicado: (2023)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

Protective immunity to liver-stage malaria
por: Holz, Lauren E, et al.
Publicado: (2016)

Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
por: Xu, Nan, et al.
Publicado: (2020)

Serum Antibodies against CD28– A New Potential Marker of Dismal Prognosis in Melanoma Patients
por: Körner, Rebecca, et al.
Publicado: (2013)

Ultrasound score combined with liver stiffness measurement by sound touch elastography for staging liver fibrosis in patients with chronic hepatitis B: a clinical prospective study
por: Huang, Kun, et al.
Publicado: (2022)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Complement in Acute Liver Failure: The Right Timing to Give a Sincere Compliment
por: Weber, Susanne N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i59g68omln9d1r4m3ojfrh8640